Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia

NCT02139267 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Genexine, Inc.